XBI ETF Chart
NYSEARCA: XBIState Street Investment ManagementHealthETFUSD
Market open · Delayed 15 min · as of Oct 8, 10:06 AM ET
XBI technical summary
XBI is trading 7.0% below its 50-day simple moving average of $158.18 and 5.6% above its 200-day average of $139.30. The 50-day average is above the 200-day average, a configuration technical analysts associate with a longer-term uptrend. The 14-day Relative Strength Index (RSI) is 38.1, within the neutral 30 to 70 band.
Over the past year, the stock ranged from $102.55 (Oct 7, 2025) to $169.89 (Aug 25, 2026); the current price sits 66% of the way from the low to the high. Annualized 30-day volatility is 25.4%. Based on the last session's high, low and close, the classic pivot point is $150.42, with first resistance at $152.21 and first support at $148.45.
These indicators describe past price behavior for State Street SPDR S&P Biotech; they are not predictions.
Summary generated from market data by MetaCap's automated system. Methodology
XBI performance
1 week
-4.72%
1 month
-7.23%
3 months
-7.82%
6 months
+14.99%
Year to date
+23.21%
1 year
+44.90%
3 years
+115.85%
5 years
+20.11%
XBI price return, excluding dividends.
Moving averages
| Period | Simple (SMA) | Exponential (EMA) |
|---|---|---|
| 5-day | 153.25Price below | 152.84Price below |
| 10-day | 154.84Price below | 154.36Price below |
| 20-day | 155.88Price below | 156.03Price below |
| 50-day | 158.18Price below | 156.16Price below |
| 100-day | 151.19Price below | 151.21Price below |
| 200-day | 139.30Price above | 140.08Price above |
Pivot points
| Level | Price |
|---|---|
| Resistance 3 (R3) | 155.97 |
| Resistance 2 (R2) | 154.18 |
| Resistance 1 (R1) | 152.21 |
| Pivot point | 150.42 |
| Support 1 (S1) | 148.45 |
| Support 2 (S2) | 146.66 |
| Support 3 (S3) | 144.69 |